First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma

Artigo Acesso aberto

First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma

2023; AME Publishing Company; Volume: 12; Issue: 4 Linguagem: Espanhol

10.21037/cco-22-111

ISSN

2304-3873

Autores

Edith Norela Benítez-Escobar, Duván Arley Galindes-Casanova, Luis Álvaro Melo-Burbano, Diana Marcela Bonilla-Bonilla, Luis Miguel Osorio-Toro, Jorge Enrique Daza Arana, Santiago Leandro Escobar-Dávila, Giovanna Patricia Rivas-Tafurt,

Tópico(s)

Chemotherapy-related skin toxicity

Resumo

Edith Norela Benitez-Escobar, Duvan Arley Galindes-Casanova, Luis Álvaro Melo-Burbano, Diana Marcela Bonilla-Bonilla, Luis Miguel Osorio-Toro, Jorge Enrique Daza-Arana, Santiago Leandro Escobar-Dávila, Giovanna Patricia Rivas-Tafurt

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma